Previous close | 60.60 |
Open | 60.49 |
Bid | 60.37 x 100 |
Ask | 60.77 x 100 |
Day's range | 59.75 - 60.86 |
52-week range | 25.98 - 110.25 |
Volume | |
Avg. volume | 1,929,620 |
Market cap | 6.352B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Deep Dive into Financials and Strategic Developments
Cytokinetics ( NASDAQ:CYTK ) First Quarter 2024 Results Key Financial Results Net loss: US$135.6m (loss widened by 3.3...
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript May 9, 2024 Cytokinetics, Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome ladies and gentlemen to Cytokinetics First Quarter 2024 Conference Call. [Operator Instructions] I will now […]